Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14547635 | 0.71 | TSHR (0.33) | — | |
| SCHEMBL1196753 | 0.70 | — | — | |
| SCHEMBL9021930 | 0.70 | — | — | |
| SCHEMBL28291376 | 0.67 | — | — | |
| SCHEMBL15421170 | 0.67 | — | — | |
| SCHEMBL1026012 | 0.67 | — | — | |
| SCHEMBL7699149 | 0.67 | — | — | |
| SCHEMBL10653217 | 0.67 | — | — | |
| Potassium Ion SCHEMBL10765420 | 0.64 | — | — | |
| SCHEMBL16627914 | 0.61 | MEN1 (0.37) | MEN1KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 64 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1611166-B1 | BUILDING SEALANT COMPOSITION | BRIDGESTONE CORP (JP) | 2007-08-29 | — | — | EP | claimed |
| US-20240071772-A1 | SUBSTRATE PROCESSING METHOD AND SUBSTRATE PROCESSING APPARATUS | TOKYO ELECTRON LIMITED (JP) | 2024-02-29 | — | — | US | disclosed |
| CN-117099188-A | Substrate processing method and substrate processing apparatus | 东京毅力科创株式会社 | 2023-11-21 | — | — | CN | disclosed |
| US-20230339947-A1 | USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS | Madera Therapeutics, LLC | 2023-10-26 | — | — | US | disclosed |
| US-11766442-B2 | T-cell lymphoma treatments | CITY OF HOPE (US) | 2023-09-26 | — | — | US | disclosed |
| US-20230147962-A1 | FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS | PHILOCHEM AG (CH) | 2023-05-11 | — | — | US | disclosed |
| WO-2022211057-A1 | SUBSTRATE PROCESSING METHOD AND SUBSTRATE PROCESSING DEVICE | 東京エレクトロン株式会社 | 2022-10-06 | — | — | WO | disclosed |
| US-11328933-B2 | Etching method, substrate processing apparatus, and substrate processing system | TOKYO ELECTRON LIMITED (JP) | 2022-05-10 | — | — | US | disclosed |
| US-20210202260-A1 | ETCHING METHOD, SUBSTRATE PROCESSING APPARATUS, AND SUBSTRATE PROCESSING SYSTEM | TOKYO ELECTRON LIMITED (JP) | 2021-07-01 | — | — | US | disclosed |
| US-10822353-B2 | Dithio ETP derivatives | CITY OF HOPE (US) | 2020-11-03 | — | — | US | disclosed |
| US-20080020127-A1 | Methods and systems for coating a medical device | ALLACCEM, INC. | 2008-01-24 | — | — | US | disclosed |
| US-20070202342-A1 | Applying to an oral surface (teeth or gums)one or more bridged polycyclic compounds comprising at least two cyclic groups defined in part by quaternary ammonium moieties; microbiocides; self-cleaning; dentistry; bonding agents, resin cements, sealants | ALLACCEM, INC. | 2007-08-30 | — | — | US | disclosed |
| EP-1497268-A4 | NITRIC OXIDE DONORS, COMPOSITIONS AND METHODS OF USE | NITROMED INC (US) | 2006-01-18 | — | — | EP | disclosed |
| EP-1497268-A2 | NITRIC OXIDE DONORS, COMPOSITIONS AND METHODS OF USE | Nitromed, Inc. (US) | 2005-01-19 | — | — | EP | disclosed |
| US-20030203915-A1 | Nitric oxide donors, compositions and methods of use related applications | NICOX S.A. (FR) | 2003-10-30 | — | — | US | disclosed |
| WO-2003086282-A2 | NITRIC OXIDE DONORS, COMPOSITIONS AND METHODS OF USE | NITROMED, INC. (US) | 2003-10-23 | — | — | WO | disclosed |
| EP-0479561-B1 | Process for heat-treating a polyolefin coating on metal in the presence of a treating agent | MITSUI PETROCHEMICAL IND (JP) | 1995-08-23 | — | — | EP | disclosed |
| US-5275848-A | Process for preparing a laminate of metal and a polyolefin resin | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1994-01-04 | — | — | US | disclosed |
| EP-0479561-A2 | Process for heat-treating a polyolefin coating on metal in the presence of a treating agent | MITSUI PETROCHEMICAL INDUSTRIES, LTD. (JP) | 1992-04-08 | — | — | EP | disclosed |
| US-4370497-A | Oxidation process using tellurium oxide catalysts | BARTON DEREK H R (FR) | 1983-01-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10822353-B2 | Dithio ETP derivatives | ETV1, ETV6, DLD | MEN1 4110/4885KMT2A 2831/4885 |
| US-20230339947-A1 | USE OF CASEINOLYTIC PROTEASE P FUNCTION AS A BIOMARKER OF DRUG RESPONSE TO IMIPRIDONE-LIKE AGENTS | CLPP, PRCP, PREP | MEN1 4322/4885KMT2A 4528/4885 |
| US-20230147962-A1 | FIBROBLAST ACTIVATION PROTEIN LIGANDS FOR TARGETED DELIVERY APPLICATIONS | FAP, FIBP, FGFR1 | MEN1 3505/4885KMT2A 4381/4885 |
| US-11766442-B2 | T-cell lymphoma treatments | MALT1, BCL6, BCL3 | MEN1 1496/4885KMT2A 857/4885 |
| US-20030203915-A1 | Nitric oxide donors, compositions and methods of use related applications | NOS1, NOS2, NOS3 | MEN1 3465/4885KMT2A 4693/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.